BDDRFVIII

recombinant factor VIII biosimilar · Wyeth

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BDDRFVIII, covering 2008-04-22 to 2008-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A [Phase 3]